Impacts of daily intakes on the isomeric profiles of perfluoroalkyl substances (PFASs) in human serum.
Impacts of daily intakes on the isomeric profiles of perfluoroalkyl substances (PFASs) in human serum.
复制标题
DOI:
10.1016/j.envint.2016.01.002
复制
发表时间:
2016-04
影响因子:
11.8
通讯作者:
Guoqiang Shan;Zhi Wang;Lianqiu Zhou;Pin Du;Xiaoxiao Luo;Qiannian Wu;Lingyan Zhu
中科院分区:
文献类型:
--
作者:
Guoqiang Shan;Zhi Wang;Lianqiu Zhou;Pin Du;Xiaoxiao Luo;Qiannian Wu;Lingyan Zhu
Perfluoroalkyl substances (PFASs) have been well studied in human daily intake for assessment of potential health risks. However, little is known about the isomeric compositions of PFASs in daily intake and their impacts on isomeric profiles in humans. In this study, we investigated the occurrence of PFASs with isomeric analysis in various human exposure matrices including foodstuffs, tap water and indoor dust. Perfluorooctanesulfonate (PFOS) and/or perfluorooctanoate (PFOA) were predominant in these exposure matrices collected in Tianjin, China. In fish and meat, linear (n-) PFOA was enriched with a percentage of 92.2% and 99.6%, respectively. Althoughn-PFOS was higher in fish (84.8%) than in technical PFOS (ca. 70%), it was much lower in meat (63.1%) and vegetables (58.5%). Dietary intake contributed > 99% of the estimated daily intake (EDI) for the general population. The isomeric profiles of PFOA and PFOS in human serum were predicted based on the EDI and a one-compartment, first-order pharmacokinetic model. The isomeric percentage ofn-PFOA in the EDI (98.6%) was similar to that in human serum (predicted: 98.2%, previously measured: 99.7%) of Tianjin residents. The results suggest direct PFOA intake plays an important role in its isomeric compositions in humans. For PFOS, the predictedn-PFOS (69.3%) was much higher than the previously measured values (59.2%) in human serum. This implies that other factors, such as indirect exposure to PFOS precursors and multiple excretion pathways, may contribute to the lower percentage ofn-PFOS in humans than of technical PFOS.